Fiduciary Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.58M Buy
6,070
+3,222
+113% +$3.27M 1.59% 7
2025
Q4
$3.06M Sell
2,848
-28
-1% -$26.8K 0.88% 16
2025
Q3
$2.19M Buy
2,876
+635
+28% +$473K 0.62% 27
2025
Q2
$1.75M Sell
2,241
-216
-9% -$168K 0.57% 31
2025
Q1
$2.03M Buy
2,457
+2,157
+719% +$1.79M 0.68% 25
2024
Q4
$232K Sell
300
-1,832
-86% -$1.52M 0.07% 49
2024
Q3
$1.89M Buy
2,132
+188
+10% +$169K 0.62% 31
2024
Q2
$1.76M Sell
1,944
-205
-10% -$164K 0.69% 31
2024
Q1
$1.67M Buy
2,149
+432
+25% +$307K 0.66% 35
2023
Q4
$1M Buy
+1,717
New +$1M 0.44% 43

Other funds holding LLY

Fiduciary Family Office's LLY Position: Q1 2026 in Review

Fiduciary Family Office increased its Eli Lilly (LLY) stake by 113% in Q1 2026, buying an estimated $3.27M and bringing the position to 6,070 shares worth $5.58M. The position accounts for 1.59% of the portfolio, ranked #7.

Fiduciary Family Office first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fiduciary Family Office held 6,070 shares of Eli Lilly worth $5.58M as of Q1 2026.
  • Fiduciary Family Office bought 3,222 Eli Lilly shares in Q1 2026, an estimated $3.27M.
  • Eli Lilly made up 1.59% of Fiduciary Family Office's portfolio in Q1 2026, its #7 holding.
  • Fiduciary Family Office first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.